Gestational Diabetes May Indicate Future Subclinical Renal Issues

Share this content:
Gestational Diabetes May Indicate Future Subclinical Renal Issues
Gestational Diabetes May Indicate Future Subclinical Renal Issues

THURSDAY, May 10, 2018 (HealthDay News) -- Gestational diabetes mellitus (GDM) may be an early indicator of subsequent subclinical renal dysfunction, according to a study published online May 4 in Diabetes Care.

Shristi Rawal, Ph.D., from the National Institutes of Health in Bethesda, Md., and colleagues used data from the Diabetes & Women's Health study (2012 to 2016) to examine the independent and joint associations of GDM and subsequent diabetes with long-term renal function among 607 women and 619 women without GDM participating in the Danish National Birth Cohort (1996 to 2002).

The researchers found that, compared with women without GDM or subsequent diabetes, women with a history of GDM had significantly higher estimated glomerular filtration rate, even if they had not subsequently developed diabetes. Women with a GDM history who later developed diabetes (183 women) also had a significantly higher urinary albumin-to-creatinine ratio (UACR) and an increased risk of elevated UACR (adjusted relative risk, 2.3) versus women with neither. When adjusting for prepregnancy body mass index and hypertension, among other potential confounders, GDM without subsequent diabetes was not related to UACR.

"These findings suggest that women with GDM-complicated pregnancies may represent a high-risk group that could benefit from regular monitoring for early-stage renal damage, timely detection of which may help clinicians initiate treatment to prevent or delay further disease progression," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »